Cospower Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 11:09 am

Competitors of Cospower Engineering Ltd

All Competitor Stocks of Cospower Engineering Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:40 pm

Below is a detailed analysis of the quarterly data for Cospower Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 20.65 Cr.. The value appears strong and on an upward trend. It has increased from 7.05 Cr. (Sep 2024) to 20.65 Cr., marking an increase of 13.60 Cr..
• For Expenses, as of Mar 2025, the value is 16.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.68 Cr. (Sep 2024) to 16.06 Cr., marking an increase of 10.38 Cr..
• For Operating Profit, as of Mar 2025, the value is 4.59 Cr.. The value appears strong and on an upward trend. It has increased from 1.37 Cr. (Sep 2024) to 4.59 Cr., marking an increase of 3.22 Cr..
• For OPM %, as of Mar 2025, the value is 22.23%. The value appears strong and on an upward trend. It has increased from 19.43% (Sep 2024) to 22.23%, marking an increase of 2.80%.
• For Other Income, as of Mar 2025, the value is -0.25 Cr.. The value appears to be declining and may need further review. It has decreased from 0.70 Cr. (Sep 2024) to -0.25 Cr., marking a decrease of 0.95 Cr..
• For Interest, as of Mar 2025, the value is 1.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.92 Cr. (Sep 2024) to 1.44 Cr., marking an increase of 0.52 Cr..
• For Depreciation, as of Mar 2025, the value is 0.96 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.91 Cr. (Sep 2024) to 0.96 Cr., marking an increase of 0.05 Cr..
• For Profit before tax, as of Mar 2025, the value is 1.94 Cr.. The value appears strong and on an upward trend. It has increased from 0.24 Cr. (Sep 2024) to 1.94 Cr., marking an increase of 1.70 Cr..
• For Tax %, as of Mar 2025, the value is 33.51%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Sep 2024) to 33.51%, marking an increase of 33.51%.
• For Net Profit, as of Mar 2025, the value is 1.29 Cr.. The value appears strong and on an upward trend. It has increased from 0.24 Cr. (Sep 2024) to 1.29 Cr., marking an increase of 1.05 Cr..
• For EPS in Rs, as of Mar 2025, the value is 8.60. The value appears strong and on an upward trend. It has increased from 1.60 (Sep 2024) to 8.60, marking an increase of 7.00.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:35 am

Growth

Last Updated: September 5, 2025, 3:06 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Cospower Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 0.77 (Mar 24) to 10.21, marking an increase of 9.44.
• For Diluted EPS (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 0.77 (Mar 24) to 10.21, marking an increase of 9.44.
• For Cash EPS (Rs.), as of Mar 25, the value is 20.32. This value is within the healthy range. It has increased from 12.53 (Mar 24) to 20.32, marking an increase of 7.79.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 108.56. It has increased from 48.15 (Mar 24) to 108.56, marking an increase of 60.41.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 108.56. It has increased from 48.15 (Mar 24) to 108.56, marking an increase of 60.41.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 165.43. It has increased from 148.62 (Mar 24) to 165.43, marking an increase of 16.81.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 38.00. This value is within the healthy range. It has increased from 25.58 (Mar 24) to 38.00, marking an increase of 12.42.
• For PBIT / Share (Rs.), as of Mar 25, the value is 26.83. This value is within the healthy range. It has increased from 13.81 (Mar 24) to 26.83, marking an increase of 13.02.
• For PBT / Share (Rs.), as of Mar 25, the value is 13.03. This value is within the healthy range. It has increased from 1.30 (Mar 24) to 13.03, marking an increase of 11.73.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 9.15. This value is within the healthy range. It has increased from 0.76 (Mar 24) to 9.15, marking an increase of 8.39.
• For PBDIT Margin (%), as of Mar 25, the value is 22.97. This value is within the healthy range. It has increased from 17.20 (Mar 24) to 22.97, marking an increase of 5.77.
• For PBIT Margin (%), as of Mar 25, the value is 16.21. This value is within the healthy range. It has increased from 9.29 (Mar 24) to 16.21, marking an increase of 6.92.
• For PBT Margin (%), as of Mar 25, the value is 7.87. This value is below the healthy minimum of 10. It has increased from 0.87 (Mar 24) to 7.87, marking an increase of 7.00.
• For Net Profit Margin (%), as of Mar 25, the value is 5.53. This value is within the healthy range. It has increased from 0.51 (Mar 24) to 5.53, marking an increase of 5.02.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.43. This value is below the healthy minimum of 15. It has increased from 1.58 (Mar 24) to 8.43, marking an increase of 6.85.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.64. This value is within the healthy range. It has increased from 10.89 (Mar 24) to 15.64, marking an increase of 4.75.
• For Return On Assets (%), as of Mar 25, the value is 2.86. This value is below the healthy minimum of 5. It has increased from 0.32 (Mar 24) to 2.86, marking an increase of 2.54.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.51. This value is within the healthy range. It has decreased from 1.54 (Mar 24) to 0.51, marking a decrease of 1.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 2.71 (Mar 24) to 1.00, marking a decrease of 1.71.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.62. It has decreased from 0.67 (Mar 24) to 0.62, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has increased from 1.18 (Mar 24) to 1.59, marking an increase of 0.41.
• For Quick Ratio (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.85, marking an increase of 0.42.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 4. It has decreased from 1.48 (Mar 24) to 1.46, marking a decrease of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.70. This value is below the healthy minimum of 3. It has increased from 2.05 (Mar 24) to 2.70, marking an increase of 0.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.63. This value is below the healthy minimum of 3. It has increased from 1.06 (Mar 24) to 1.63, marking an increase of 0.57.
• For Enterprise Value (Cr.), as of Mar 25, the value is 136.73. It has increased from 53.53 (Mar 24) to 136.73, marking an increase of 83.20.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has increased from 2.40 (Mar 24) to 4.94, marking an increase of 2.54.
• For EV / EBITDA (X), as of Mar 25, the value is 21.49. This value exceeds the healthy maximum of 15. It has increased from 13.95 (Mar 24) to 21.49, marking an increase of 7.54.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.59. This value exceeds the healthy maximum of 3. It has increased from 1.53 (Mar 24) to 4.59, marking an increase of 3.06.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 7.00. This value exceeds the healthy maximum of 3. It has increased from 4.74 (Mar 24) to 7.00, marking an increase of 2.26.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.59. This value exceeds the healthy maximum of 3. It has increased from 1.53 (Mar 24) to 4.59, marking an increase of 3.06.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness